In the arena of lung cancer, new researches and studies are being carried out all around the world to help the patients in its early detection and timely cure. One of the…
Category: Lung Cancer News
Lung Cancer Screening in Non-Smoker Women in Taiwan Associated with Overdiagnosis
A new study based on data from a National Cancer Registry in Taiwan has found that lung cancer screening may lead to overdiagnosis at the population level. The United States Preventive Services…
NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer
There are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups depending on where and how…
Study Finds Blood Tests to help Predict Lung Cancer Screenings
According to a new study published in the Journal of Clinical Oncology, a blood test along with a risk model based on person’s history can more accurately find whether the person can…
Study: Lung Cancer Screenings Associated with Death Decline
Lung cancer is one of the leading causes of cancer deaths in the United States and is diagnosed in more than 2lac people annually. According to a Mount Sinai study published in…
Study Shows Treating Depression Could Lengthen Lung Cancer Survival
Depression is a common symptom that comes with patients suffering from lung cancer. During the journey from lung cancer diagnosis to its treatment, involves significant time and various treatment processes. Some patients…
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumors express PD-L1=1%, as determined…
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…